| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 02/04/2010 | WO2010014909A1 Immunomodulatory peptides |
| 02/04/2010 | WO2010014616A2 Prominin-1 peptide fragments and uses thereof |
| 02/04/2010 | WO2010013485A1 Melk epitope peptides and vaccines containing the same |
| 02/04/2010 | WO2010012850A1 Cell-penetrating peptides and uses |
| 02/04/2010 | WO2010012786A1 Method for processing microbiologically produced cyclic oligopeptides |
| 02/04/2010 | WO2010012073A1 Nonimmunosuppressive cyclosporine analogue molecules |
| 02/04/2010 | WO2009139887A3 Non-inflammatory gluten peptide analogues as biomarkers for celiac sprue |
| 02/04/2010 | US20100029573 Tumor-associated peptides that bind to mhc-molecules |
| 02/04/2010 | US20100029572 Neurotrophic Peptides |
| 02/04/2010 | US20100029571 Novel and powerful mhc-class ii peptides derived from survivin |
| 02/04/2010 | US20100029570 Peptide and treatment for hiv-1 infection |
| 02/04/2010 | US20100029552 Peptide inhibitors of c-jun dimerization and uses thereof |
| 02/04/2010 | US20100029547 Mvl, an antiviral protein from a cyanobacterium |
| 02/04/2010 | US20100029016 Nano-Sized Optical Fluorescence Labels and Uses Thereof |
| 02/04/2010 | US20100028375 Vlp based vaccine delivery system |
| 02/04/2010 | US20100028373 Peptide vaccines for cancers expressing mphosph1 or depdc1 polypeptides |
| 02/04/2010 | US20100028298 Interferon type i supporting compounds |
| 02/04/2010 | CA2732721A1 Melk epitope peptides and vaccines containing the same |
| 02/04/2010 | CA2732146A1 Nonimmunosuppressive cyclosporine analogue molecules |
| 02/04/2010 | CA2732108A1 Prominin-1 peptide fragments and uses thereof |
| 02/03/2010 | EP2148692A2 Melanocortin receptor ligands modified with hydantoin |
| 02/03/2010 | CN101641372A Template-fixed peptidomimetics |
| 02/03/2010 | CN101641371A 肽及其用途 Peptides and their uses |
| 02/03/2010 | CN101641370A Basic peptides and their use as combined antibacterial-antifungine agents |
| 02/03/2010 | CN101641369A FOXP3 peptide vaccine |
| 02/03/2010 | CN101638433A Peptide mimics of conserved gonococcal epitopes and methods and compositions using them |
| 02/03/2010 | CN101638432A Rana pleuraden antioxidant peptide and genes and application thereof |
| 02/03/2010 | CN101638431A Polypeptide capable of combining with NKp80 receptor and application thereof |
| 02/03/2010 | CN101638430A Anti-tuberculosis CTL epitope peptide |
| 02/03/2010 | CN101638429A Small molecular peptide of specificity recognition cell surface integrin alphal3beta1 |
| 02/03/2010 | CN100586959C Peptides capable of binding to titanium, silver and silicone |
| 02/03/2010 | CN100586485C Methods of radiofluorination of biologically active vectors |
| 02/02/2010 | US7655752 TNF-α converting enzyme inhibitory agents and method of using same |
| 02/02/2010 | US7655643 (8S,11S,14S)-14-Amino-11-(3-aminopropyl)-5-fluoro -17-hydroxy-10,13-dioxo-9,12-diazatricyclo[14.3.1.12,6]henicosa-1(20),2(21),3,5,16,18-hexaene-8-carboxylic acid dihydrochloride; antibacterial activity on S. aureus strains which are resistant to biphenomycin |
| 02/02/2010 | US7655629 Peptides and their use for the treatment of HIV infections |
| 02/02/2010 | US7655624 Peptide and peptide mimetic conjugates with integrin-inhibitor properties |
| 02/02/2010 | US7655623 Dab9 derivatives of lipopeptide antibiotics and methods of making and using the same |
| 02/02/2010 | US7655621 Cross-linked glycopeptide-cephalosporin antibiotics |
| 02/02/2010 | US7655617 Conjugates of soluble peptidic compounds with membrane-binding agents |
| 02/02/2010 | US7655602 Peptides comprising aromatic D-amino acids and methods of use |
| 02/02/2010 | US7655464 Dual inhibitors of HIV-1 GP-120 interactions |
| 02/02/2010 | US7655463 Treating neuropathic pain, particularly diabetic peripheral neuropathy, by administering a truncated neublastin polypeptide; activating a RET receptor tyrosine kinase |
| 02/02/2010 | US7655239 Peptides for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 02/02/2010 | CA2272573C Peptide derived from an antigen recognized by autoantibodies from patients with rheumatoid arthritis, antibody directed against said peptide, a combinatorial antigen, and a methodof detecting auto-immune antibodies |
| 02/02/2010 | CA2257973C T cell antigen receptor peptides |
| 02/02/2010 | CA2142331C Immunoglobulins devoid of light chains |
| 01/28/2010 | WO2010011999A2 Methods and compositions for eliciting an amyloid-selective immune response |
| 01/28/2010 | WO2010011994A2 Polypeptides and uses thereof |
| 01/28/2010 | WO2009129173A3 Methods, antibodies and kits for detecting cerebrospinal fluid in a sample |
| 01/28/2010 | US20100022448 Peptides |
| 01/28/2010 | US20100022445 Biologically active peptides |
| 01/28/2010 | US20100021967 Alpha Factor Signal Peptide For Producing a Polypeptide |
| 01/28/2010 | US20100021939 Process for detecting enzyme activity in an immunoassay |
| 01/28/2010 | US20100021510 Neuronal exocytosis inhibiting peptides |
| 01/28/2010 | US20100021468 Novel mhc class ii restricted t cell epitopes from the cancer anitgen, ny eso-1 |
| 01/28/2010 | US20100021441 Mhc molecule-binding tumor-associated peptides |
| 01/28/2010 | US20100021381 Natriuretic peptide-mediated imaging of atherosclerotic plaque |
| 01/27/2010 | EP2147925A1 Compositions of lipopeptide antibiotic derivatives and methods of use thereof |
| 01/27/2010 | EP2146753A2 18f fluoro-benzoyl labelled biological active compounds as diagnostic imaging agents as well as benzotriazol-1-yloxy-benzoyl , 2,5-dioxo-pyrrolidin-1-yloxy)benzoyl and trimethylammonio-benzoyl precursers thereof |
| 01/27/2010 | EP2146734A2 Novel peptide amphiphiles having improved solubility and methods of using same |
| 01/27/2010 | EP1692186B1 Cancer cell targeting gene delivery method |
| 01/27/2010 | CN101636408A 肽 Peptide |
| 01/27/2010 | CN101633689A Peptide selection method |
| 01/27/2010 | CN101633636A Peptidomimetic protease inhibitors |
| 01/27/2010 | CN100584946C Method of humanizing immune system molecules |
| 01/27/2010 | CN100584859C Process for the preparation of echinocandin derivatives |
| 01/26/2010 | US7651997 Deoxo-proline-containing tamandarin and didemnin analogs, dehydro-proline-containing tamandarin and didemnin analogs, and methods of making and using them |
| 01/26/2010 | CA2328803C Anti-procalcitonin antibodies and the preparation and use thereof |
| 01/26/2010 | CA2213301C Immunoreactive and immunotherapeutic molecules which interact in subjects with insulin-dependent diabetes mellitus (iddm) |
| 01/26/2010 | CA2201841C Peptide specificity of anti-myelin basic protein and the administration of myelin basic protein peptides to multiple sclerosis patients |
| 01/26/2010 | CA2188817C Angiogenesis inhibitor |
| 01/21/2010 | WO2010009227A2 Recombinant pokeweed antiviral proteins, compositions and methods related thereto |
| 01/21/2010 | WO2010009065A2 Amphipathic peptide compositions |
| 01/21/2010 | WO2010008493A2 Processes for preparing high purity aza cyclohexapeptides |
| 01/21/2010 | WO2010008436A1 Methods and compositions for inhibition of bcl6 repression |
| 01/21/2010 | WO2010007724A1 Peptide capable of binding to epcam |
| 01/21/2010 | WO2010007723A1 Peptide capable of binding to ceramic material |
| 01/21/2010 | WO2010007147A1 Anticancer compounds |
| 01/21/2010 | WO2010006720A1 Anti-amyloid immunogenic compositions, methods and uses |
| 01/21/2010 | WO2010006682A1 Method for producing intermediates for the production of novel macrocycles that are inhibitors of the proteasomic degradation of p27, such as argyrin and derivatives thereof, and uses of said macrocycles |
| 01/21/2010 | WO2010006476A1 Myocardial peptide, preparation method and uses thereof |
| 01/21/2010 | WO2010006377A1 Therapeutic agents |
| 01/21/2010 | WO2009149279A3 Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders |
| 01/21/2010 | WO2009130612A3 Prion epitopes and methods of use thereof |
| 01/21/2010 | WO2009129220A3 Plectin-1 targeted agents for detection and treatment of pancreatic ductal adenocarcinoma |
| 01/21/2010 | WO2009127845A8 Process for the preparation of network polymer compositions |
| 01/21/2010 | US20100016549 Peyer's patch and/or m-cell targeting ligands |
| 01/21/2010 | US20100016548 Self-assembling peptide and gel produced from the same |
| 01/21/2010 | US20100016242 Myosin light chain kinase inhibitors and methods of use |
| 01/21/2010 | US20100016241 Methods and compositions for inhibiting c-met dimerization and activation |
| 01/21/2010 | US20100016239 Heparin binding motif and use thereof |
| 01/21/2010 | US20100016238 Peptides for Use in the Treatment of Obesity |
| 01/21/2010 | US20100016237 Novel Peptides for Use in the Treatment of Obesity |
| 01/21/2010 | US20100016236 Osteogenic synthetic peptides, pharmaceutical compositions comprising the same, and medium containing the same |
| 01/21/2010 | US20100016227 Ligand/lytic peptide compositions and methods of use |
| 01/21/2010 | US20100016225 CONJUGATES COMPRISED OF POLYMER AND HIV gp-41-DERIVED PEPTIDES AND THEIR USE IN THERAPY |
| 01/21/2010 | US20100016167 Antimicrobial linear peptides |
| 01/21/2010 | US20100015197 Amphiphilic peptides and hydrogel matrices thereof for bone repair |
| 01/21/2010 | US20100015169 Tumor Antigens |
| 01/21/2010 | US20100015154 Immunogenic memapsin 2 b-secretase peptides and methods of use |